Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 6, 2013
[Efficacy of radiotherapy for adult patients with Langerhans cell histiocytosis]Ming-hui Duan, Xiao Han, Jian Li, et al.
BMC Cardiovascular Disorders|April 16, 2022
Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort studyXiao-Hang Liu, Jia-Yu Shi, Ding-Ding Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 26, 2016
[CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation]Yue-Hua Huang, Wei Zhang, Hao Cai, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|September 4, 2007
Peripheral blood CD34+ cell mobilization in 42 patients with severe autoimmune diseaseWei Zhang, Dao-Bin Zhou, Yan Zhao, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|December 9, 2009
[Comparison of efficacy and adverse effects between arsenic trioxide and all-trans retinoic acid in patients with acute promyelocytic leukemia]Li Jiao, Shu-Jie Wang, Jun-Ling Zhuang, et al.
Cancer Medicine|October 22, 2022
Front-line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real-world setting: A multicenter retrospective study in ChinaLi Bao, Ai-Jun Liu, Bin Chu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 17, 2011
[Porcine anti-human lymphocyte globulin plus cyclosporine A therapy for severe aplastic anemia]Bing Han, Si-yi Yan, Nong Zou, et al.
Frontiers in Oncology|July 22, 2022
Machine Learning-Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life DataLi Bao, Yu-Tong Wang, Jun-Ling Zhuang, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 26, 2017
Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in ChinaXiao-Han Xu, Lu Zhang, Xin-Xin Cao, et al.
Cancer Medicine|April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort studyAijun Liu, Hong Yu, Rui Hou, et al.
Pageof 3